Skip to content

CorMedix CRMD Effective Income Tax Rate Reconciliation, Tax Credit, Percent

Effective Income Tax Rate Reconciliation, Tax Credit, Percent at other companies

Popular logo
PopularBPOP
0.8%
Churchill Downs logo
Churchill DownsCHDN
0.2%+0.1pp
Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
11.6%
Kyndryl Holdings logo
Kyndryl HoldingsKD
13.1%+7.8pp
BancFirst Corporation logo
BancFirst CorporationBANF
1%
CONMED logo
CONMEDCNMD
2.7%+1.2pp

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's effective income tax rate reconciliation, tax credit, percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's effective income tax rate reconciliation, tax credit, percent?
CorMedix (CRMD) reported effective income tax rate reconciliation, tax credit, percent of 835% in Q4 2024.
What does effective income tax rate reconciliation, tax credit, percent mean?
Represents the impact of various tax credits on the company's effective tax rate compared to the statutory rate. This metric highlights how specific government incentives or credits reduce the overall tax burden for the organization. Investors use this to assess the sustainability of tax savings derived from R&D or other qualifying activities.